Competing in the Global Contract Manufacturing Market
What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business
28-Oct-2013
Global
Customer Research
The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 40–50% range across all product types, indicating opportunity for CMO vendor switching in the future. Of all parameters used in CMO agreements and selection, “volume commitments” ranks as the most important while “capacity and site transfer” ranks second. Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies which possess operations in the same region.
Introduction
- Title, Research Team, and Table of Contents
Research Objectives
- Research Objectives and Methodology
Executive Summary
- Executive Summary
An Overview of the Global Contract Manufacturing Market
- Overview
Impact of Attitudes and Perceptions on CMO Outsourcing
- Segmentation of Global Pharmaceutical and Biotechnology Companies
Preferred CMOs and Drivers of their Selection
- Overview
The Outsourcing and Manufacturing Markets
- Assessing Growth Opportunities and Threats
Areas of Marketing Opportunities
- Overview
Appendices
- Additional Details
The Frost & Sullivan Story
- Overview
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Deliverable Type | Customer Research |
---|---|
No Index | No |
Podcast | No |
Author | Karolina Olszewska |
WIP Number | ND00-01-00-00-00 |
Is Prebook | No |